|

Cytokine Induced Memory-like Natural Killer (CIML NK) Cells Clinical Trials

1 actively recruiting trial across 1 location

Also known as: NK Cells

Pipeline

Early 1: 1

Top Sponsors

  • Dana-Farber Cancer Institute1

Indications

  • Translocation Renal Cell Carcinoma1
  • Chromophobe Renal Cell Carcinoma1
  • Renal Carcinoma1
  • Renal Cell Carcinoma1
  • Urothelial Carcinoma1

Boston, Massachusetts1 trial

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

Brigham and Women's Hospital

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.